Related Experiment Video

Updated: Jan 4, 2026

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
23:56

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model

Published on: October 31, 2010

17.1K

Machine Learning for Human Immunodeficiency Virus Prevention in Rural Africa: The SEARCH for Sustainability

Douglas S Krakower1,2,3, Julia L Marcus2,3

  • 1Division of Infectious Diseases, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|November 8, 2019
PubMed
Abstract

No abstract available in PubMed .

Keywords:
HIVmachine learningprediction modelpreexposure prophylaxisprevention

More Related Videos

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
19:57

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Published on: March 30, 2014

19.0K
Humanized NOG Mice for Intravaginal HIV Exposure and Treatment of HIV Infection
08:15

Humanized NOG Mice for Intravaginal HIV Exposure and Treatment of HIV Infection

Published on: January 31, 2020

9.0K

Related Experiment Videos

Last Updated: Jan 4, 2026

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
23:56

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model

Published on: October 31, 2010

17.1K
An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
19:57

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Published on: March 30, 2014

19.0K
Humanized NOG Mice for Intravaginal HIV Exposure and Treatment of HIV Infection
08:15

Humanized NOG Mice for Intravaginal HIV Exposure and Treatment of HIV Infection

Published on: January 31, 2020

9.0K

Related Concept Videos

Steps in Outbreak Investigation01:18

Steps in Outbreak Investigation

454
In the ever-evolving field of public health, statistical analysis serves as a cornerstone for understanding and managing disease outbreaks. By leveraging various statistical tools, health professionals can predict potential outbreaks, analyze ongoing situations, and devise effective responses to mitigate impact. For that to happen, there are a few possible stages of the analysis:
454
Principles of Disease Surveillance01:26

Principles of Disease Surveillance

431
Disease surveillance is the systematic collection, analysis, and interpretation of health data essential to the planning, implementation, and evaluation of public health practice. This process integrates data dissemination to entities responsible for preventing and controlling disease, injury, and disability. Surveillance systems provide crucial information for action, helping public health authorities make informed decisions to manage and prevent outbreaks, ensure public safety, optimize...
431

Articles linked to this work by shared authors, journal, and citation graph.

PrEP reinitiation, uptake, and persistence as targets for reducing HIV incidence and racial and ethnic inequities among men who have sex with men in Boston, USA: a network modeling study.

Lancet regional health. Americas·2026

Evolving drivers of preexposure prophylaxis discontinuation among US MSM, 2018-2024.

AIDS (London, England)·2026

Potential Risks and Benefits of Low-Barrier Access and Monitoring for HIV Preexposure Prophylaxis: A Modeling Study.

The Journal of infectious diseases·2026

Long-Acting Injectable Cabotegravir HIV PrEP Uptake, Adherence, and Persistence in Two Large US Integrated Healthcare Systems.

Journal of acquired immune deficiency syndromes (1999)·2026

Contributions of Qualitative Methods to Real-Time Implementation Strategy Design: A Case Study Linking Justice Involved Individuals at Risk for HIV to Pre-exposure Prophylaxis.

International journal of qualitative methods·2026

Persistent HIV Transmission Misconceptions Among People Who Inject Drugs in Massachusetts, USA.

AIDS and behavior·2026

Influenza vaccine effectiveness against influenza A-associated hospitalization and severe in-hospital outcomes among adults in the United States, 2024-2025.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026

Ethical Priorities for Candida auris Screening in Solid Organ Transplantation.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026

Long-term Antiretroviral Therapy and Anogenital Cancer Risk.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026

Glecaprevir/Pibrentasvir Concentrations in the Breastmilk of Lactating Women.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026

Effectiveness of timely hepatitis B birth dose vaccination to prevent mother-to-child transmission in Ethiopia.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026

Gender Differences in Hepatitis C Care Outcomes in the New York City Jail System, 2019-2023: A Retrospective Cohort Study.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026

Misconceptions and health-seeking behavior among diabetic patients regarding foot ulcers: the hidden role of circulatory awareness in preventing amputation.

Frontiers in public health·2026

Pyocyanin reversibly inhibits Chlamydia by impairing newly formed elementary body infectivity and delaying the developmental cycle.

Frontiers in pharmacology·2026

Knowledge and attitude toward HIV pre-exposure prophylaxis among women of reproductive age in Tanzania: Insights from the 2022 Tanzania health demographic survey.

Medicine·2026

Disability and Biomedical HIV Prevention: The Missing Equity Dimension.

Viruses·2026

Towards Better Vaccines: Enhancing Benefits, Mitigating Risks.

Vaccines·2026

Clinical and Public Health Lessons from a Point-Source Polymicrobial Foodborne Outbreak: Implications for Vaccination of Vulnerable Populations.

Vaccines·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us